Home/ Supplements/ Reishi/ UltraImmune9

UltraImmune9

product on market Capsule Get Healthy Again Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 13% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This blend contains a variety of medicinal mushrooms, including Ganoderma lucidum and Cordyceps sinensis, which are studied for their potential immune-modulating properties. Current research evidence for these specific ingredients is limited. The formulation maintains a high safety profile with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for UltraImmune9
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
13%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Trametes versicolor
165 mg
Agaricus blazei
165 mg
Grifola frondosus
165 mg
Market median: 340.0mg (243 products) 3 studies — no high-quality reviews
Cordyceps sinensis
165 mg
Lentinula edodes
165 mg
Polyporous umbrellatus
165 mg
Flammulina velutipes
165 mg
Hericium erinaceus
165 mg
Chokeberry
165 mg
N-Acetyl-Cysteine
165 mg
42 mg
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
Cranberry powder
42 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)
Aulterra
6 mg
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Daily Use: 3 capsules per day with food or as recommended by your health care professional.

Warnings & Precautions

Warning: Pregnant or nursing women should consult their doctor before taking this or any other supplement.

Keep out of the reach of children.

Additional Information

GHA Naturals

Proprietary mushroom blend supports immune system function

650mg

Vegetable capsules

Metadata

Product Details

UPC / SKU7 53182 13965 4
DSLD Entry Date2018-02-23
Product TypeOther Combinations
FormCapsule
DSLD ID81566
Data Updated2026-04-11
Research

Research Evidence

6
Research Sources
60
Avg Quality
3
Meta Analysis
3
Rct
B Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Ganoderma lucidum (Reishi mushroom) for cancer treatment
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
C Dynamic biomarkers indicate the immunological benefits provided by Ganoderma spore powder in post-operative breast and lung cancer patients
Rct Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 PubMed DOI
C Efficacy of Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Supplementation on Psychological Stress and Selective Fitness Profile Parameters in Female College Students in West Bengal, India
Rct International journal of medicinal mushrooms 2024 PubMed DOI
C Preliminary Efficacy and Safety of Reishi & Privet Formula on Quality of Life Among Non-Small Cell Lung Cancer Patients Undergoing Chemotherapy: A Randomized Placebo-Controlled Trial
Rct Integrative cancer therapies 2020 PubMed DOI
View all evidence for Reishi →
Compare

Similar Products

View all Reishi products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.